{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-320325","form_type":"8-K","ticker":"FATE","cik":"0001434316","company_name":"FATE THERAPEUTICS INC","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.573757+00:00","generated_at":"2026-06-28T12:49:21.140951+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Fate Therapeutics files $350M ATM equity offering with Jefferies; terminates prior Leerink facility","bullets":["Filed universal shelf registration on Form S-3ASR for common stock, preferred stock, debt securities, warrants, and units.","Entered Open Market Sale Agreement with Jefferies to sell up to $350M of common stock in at-the-market offerings.","Jefferies will receive a 3% commission on gross proceeds; company not obligated to sell any shares.","Terminated prior at-the-market sales agreement dated November 21, 2018 with Leerink Partners effective upon filing.","Either party may suspend or terminate the offering upon notice subject to conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-320325","json":"https://secwatch.observer/filing/0001193125-21-320325.json","markdown":"https://secwatch.observer/filing/0001193125-21-320325.md","text":"https://secwatch.observer/filing/0001193125-21-320325.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434316/000119312521320325/0001193125-21-320325-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434316/000119312521320325/d212515d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:49:21.140951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}